Search Legislation

Access to Medical Treatments (Innovation) Act 2016

What Version

 Help about what version

Advanced Features

 Help about advanced features

Opening Options

 Help about opening options

Status:

This version of this cross heading contains provisions that are prospective. Help about Status

Close

Status

The term provision is used to describe a definable element in a piece of legislation that has legislative effect – such as a Part, Chapter or section. A version of a provision is prospective either:

  1. where the provision (Part, Chapter or section) has never come into force or;
  2. where the text of the provision is subject to change, but no date has yet been appointed by the appropriate person or body for those changes to come into force.

Commencement Orders listed in the ‘Changes to Legislation’ box as not yet applied may bring this prospective version into force.

Changes to legislation:

There are currently no known outstanding effects for the Access to Medical Treatments (Innovation) Act 2016, Cross Heading: Database of innovative medical treatments. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.

Prospective

Database of innovative medical treatmentsE+W

2Database of innovative treatmentsE+W

(1)The Secretary of State may by regulations make provision conferring functions on the Health and Social Care Information Centre (“the HSCIC”) in connection with the establishment, maintenance and operation of a database containing information about—

(a)innovative medical treatments carried out by doctors in England, and

(b)the results of such treatments.

(2)In this section, “innovative medical treatment” means medical treatment for a condition that involves a departure from the existing range of accepted medical treatments for the condition.

(3)Regulations under subsection (1) may in particular—

(a)confer power on the HSCIC to make provision about—

(i)the information to be recorded in the database, and

(ii)procedures relating to the recording of information in the database;

(b)make provision for and in connection with access to information recorded in the database.

(4)The provision that may be made by virtue of subsection (3)(b) includes, in particular—

(a)provision requiring or authorising the HSCIC to disclose information—

(i)to specified persons or descriptions of person, or

(ii)for use for specified purposes;

(b)provision requiring or authorising the HSCIC to impose conditions to be complied with by persons to whom information is disclosed by virtue of paragraph (a) (which may include conditions restricting the use or further disclosure of information).

(5)Regulations under subsection (1) may be made in relation to innovative medical treatments generally or innovative medical treatments falling within a specified description.

(6)Before making regulations under subsection (1) the Secretary of State must consult the HSCIC.

(7)In this section, “specified” means specified in regulations under subsection (1).

(8)The power to make regulations under subsection (1) is exercisable by statutory instrument; and an instrument containing such regulations is subject to annulment in pursuance of a resolution of either House of Parliament.

3Section 2: supplementaryE+W

(1)In section 2, “doctor” means a registered medical practitioner.

(2)For the purposes of section 2(2), the kinds of medical treatment that may be innovative medical treatments include (amongst other things)—

(a)the off-label use of an authorised medicinal product, and

(b)the use of a medicinal product in respect of which no marketing authorisation is in force.

(3)In subsection (2)(a), the reference to the off-label use of an authorised medicinal product is a reference to the use of the product—

(a)for a purpose other than one for which its use is specified,

(b)in relation to a person who is not within a description of persons for whom its use is specified, or

(c)in any other way in which its use is not specified.

(4)In this section—

(a)authorised medicinal product” means a medicinal product in respect of which a marketing authorisation is in force;

(b)marketing authorisation” and “medicinal product” have the same meanings as in the Human Medicines Regulations 2012 (S.I. 2012/1916);

(c)specified”, in relation to a medicinal product, means specified in its marketing authorisation.

(5)References in section 2 to medical treatment include references to treatment carried out for the purposes of medical research (but nothing in section 2 is to be read as affecting the regulation of medical research).

(6)Nothing in section 2 applies in relation to treatment which is carried out solely for cosmetic purposes.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Notes

Text created by the government department responsible for the subject matter of the Act to explain what the Act sets out to achieve and to make the Act accessible to readers who are not legally qualified. Explanatory Notes were introduced in 1999 and accompany all Public Acts except Appropriation, Consolidated Fund, Finance and Consolidation Acts.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources